DANIEL JANNEY Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DANIEL JANNEY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DANIEL JANNEY. DANIEL JANNEY is Director in VIVEVE MEDICAL, INC. ($VIVMF) and Director in SUTRO BIOPHARMA INC ($STRO) and Director in Esperion Therapeutics, Inc. ($ESPR) and Director in Allakos Inc. ($ALLK) and Director in Neothetics, Inc. ($NEOT) and Director in Krystal Biotech, Inc. ($KRYS).
Latest Insider Trading Transactions of DANIEL JANNEY
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALLK, ESPR, NEOT, KRYS, STRO, VIVE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30 2021 | ALLK | Allakos Inc. | JANNEY DANIEL | Director | Sell | S | 116.09 | 2,500 | 290,225 | 56,293 | 58.8 K to 56.3 K (-4.25 %) |
| Mar 30 2021 | ALLK | Allakos Inc. | JANNEY DANIEL | Director | Sell | S | 115.01 | 14,808 | 1,703,068 | 58,793 | 73.6 K to 58.8 K (-20.12 %) |
| Mar 24 2021 | ALLK | Allakos Inc. | JANNEY DANIEL | Director | Sell | S | 120.22 | 4,118 | 495,066 | 73,601 | 77.7 K to 73.6 K (-5.30 %) |
| Mar 24 2021 | ALLK | Allakos Inc. | JANNEY DANIEL | Director | Sell | S | 119.46 | 9,030 | 1,078,724 | 77,719 | 86.7 K to 77.7 K (-10.41 %) |
| Mar 16 2021 | ALLK | Allakos Inc. | JANNEY DANIEL | Director | Sell | S | 124.56 | 6,708 | 835,548 | 86,749 | 93.5 K to 86.7 K (-7.18 %) |
| Mar 16 2021 | ALLK | Allakos Inc. | JANNEY DANIEL | Director | Sell | S | 124.18 | 4,071 | 505,537 | 93,457 | 97.5 K to 93.5 K (-4.17 %) |
| Mar 11 2021 | ALLK | Allakos Inc. | JANNEY DANIEL | Director | Sell | S | 124.62 | 6,006 | 748,468 | 97,528 | 103.5 K to 97.5 K (-5.80 %) |
| Mar 11 2021 | ALLK | Allakos Inc. | JANNEY DANIEL | Director | Sell | S | 125.00 | 100 | 12,500 | 103,534 | 103.6 K to 103.5 K (-0.10 %) |
| Aug 07 2020 | KRYS | Krystal Biotech, I ... | JANNEY DANIEL | Director | Option Exercise | A | 41.42 | 6,800 | 281,656 | 6,800 | |
| May 29 2020 | ESPR | Esperion Therapeut ... | JANNEY DANIEL | Director | Buy | J | 0.00 | 24,565 | 0 | 24,565 | 0 to 24.6 K |
| May 29 2020 | ESPR | Esperion Therapeut ... | JANNEY DANIEL | Director | Grant | A | 0.00 | 6,106 | 0 | 11,073 | 5 K to 11.1 K (+122.93 %) |
| May 28 2020 | ALLK | Allakos Inc. | JANNEY DANIEL | Director | Option Exercise | A | 72.54 | 7,700 | 558,558 | 7,700 | |
| Sep 03 2019 | KRYS | Krystal Biotech, I ... | JANNEY DANIEL | Director | Sell | S | 46.18 | 32,190 | 1,486,534 | 366,362 | 398.6 K to 366.4 K (-8.08 %) |
| Sep 03 2019 | KRYS | Krystal Biotech, I ... | JANNEY DANIEL | Director | Sell | S | 47.50 | 700 | 33,250 | 398,552 | 399.3 K to 398.6 K (-0.18 %) |
| Sep 03 2019 | KRYS | Krystal Biotech, I ... | JANNEY DANIEL | Director | Sell | S | 46.61 | 55,794 | 2,600,558 | 399,252 | 455 K to 399.3 K (-12.26 %) |
| Jun 19 2019 | STRO | SUTRO BIOPHARMA, I ... | JANNEY DANIEL | Director | Option Exercise | A | 11.12 | 11,610 | 129,103 | 11,610 | |
| Jun 11 2019 | ALLK | Allakos Inc. | JANNEY DANIEL | Director | Option Exercise | A | 40.00 | 16,000 | 640,000 | 16,000 | |
| May 31 2019 | ESPR | Esperion Therapeut ... | JANNEY DANIEL | Director | Grant | A | 0.00 | 4,967 | 0 | 4,967 | 0 to 5 K |
| May 31 2019 | ESPR | Esperion Therapeut ... | JANNEY DANIEL | Director | Buy | J | 0.00 | 24,565 | 0 | 24,565 | 0 to 24.6 K |
| May 31 2019 | ESPR | Esperion Therapeut ... | JANNEY DANIEL | Director | Grant | A | 0.00 | 4,967 | 0 | 4,967 | 0 to 5 K |
| May 31 2019 | ESPR | Esperion Therapeut ... | JANNEY DANIEL | Director | Buy | J | 0.00 | 24,565 | 0 | 24,565 | 0 to 24.6 K |
| Jan 02 2019 | VIVE | VIVEVE MEDICAL, IN ... | JANNEY DANIEL | Director | Grant | A | 0.00 | 21,131 | 0 | 60,579 | 39.4 K to 60.6 K (+53.57 %) |
| Oct 25 2018 | VIVE | VIVEVE MEDICAL, IN ... | JANNEY DANIEL | Director | Option Exercise | A | 3.47 | 17,500 | 60,725 | 17,500 | |
| Oct 04 2018 | VIVE | VIVEVE MEDICAL, IN ... | JANNEY DANIEL | Director | Grant | A | 0.00 | 8,947 | 0 | 39,448 | 30.5 K to 39.4 K (+29.33 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | JANNEY DANIEL | Director | Option Exercise | C | 0.00 | 18,698,578 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | JANNEY DANIEL | Director | Option Exercise | C | 0.00 | 9,449,318 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | JANNEY DANIEL | Director | Option Exercise | C | 0.00 | 12,387,324 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | JANNEY DANIEL | Director | Option Exercise | C | 0.00 | 10,201,769 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | JANNEY DANIEL | Director | Buy | C | 0.00 | 514,211 | 0 | 1,944,901 | 1.4 M to 1.9 M (+35.94 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | JANNEY DANIEL | Director | Buy | C | 0.00 | 382,698 | 0 | 1,430,690 | 1 M to 1.4 M (+36.52 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | JANNEY DANIEL | Director | Buy | C | 0.00 | 458,331 | 0 | 1,047,992 | 589.7 K to 1 M (+77.73 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | JANNEY DANIEL | Director | Buy | C | 0.00 | 589,661 | 0 | 589,661 | 0 to 589.7 K |
| Sep 27 2018 | STRO | SUTRO BIOPHARMA IN ... | JANNEY DANIEL | Director | Option Exercise | A | 15.00 | 26,033 | 390,495 | 26,033 | |
| Jul 23 2018 | ALLK | Allakos Inc. | JANNEY DANIEL | Director | Option Exercise | C | 0.00 | 1,239,007 | 0 | 0 | |
| Jul 23 2018 | ALLK | Allakos Inc. | JANNEY DANIEL | Director | Option Exercise | C | 0.00 | 10,030,193 | 0 | 0 | |
| Jul 23 2018 | ALLK | Allakos Inc. | JANNEY DANIEL | Director | Buy | P | 18.00 | 250,000 | 4,500,000 | 11,519,200 | 11.3 M to 11.5 M (+2.22 %) |
| Jul 23 2018 | ALLK | Allakos Inc. | JANNEY DANIEL | Director | Buy | C | 0.00 | 11,269,200 | 0 | 11,269,200 | 0 to 11.3 M |
| Jul 03 2018 | VIVE | VIVEVE MEDICAL, IN ... | JANNEY DANIEL | Director | Grant | A | 0.00 | 8,437 | 0 | 30,501 | 22.1 K to 30.5 K (+38.24 %) |
| Jun 04 2018 | KRYS | Krystal Biotech, I ... | JANNEY DANIEL | Director | Option Exercise | A | 10.29 | 7,500 | 77,175 | 7,500 | |
| May 25 2018 | ESPR | Esperion Therapeut ... | JANNEY DANIEL | Director | Option Exercise | A | 38.32 | 10,100 | 387,032 | 10,100 | |
| May 23 2018 | VIVE | VIVEVE MEDICAL, IN ... | JANNEY DANIEL | Director | Option Exercise | A | 1.75 | 17,500 | 30,625 | 17,500 | |
| Apr 04 2018 | VIVE | VIVEVE MEDICAL, IN ... | JANNEY DANIEL | Director | Grant | A | 0.00 | 6,450 | 0 | 22,064 | 15.6 K to 22.1 K (+41.31 %) |
| Jan 22 2018 | ESPR | Esperion Therapeut ... | JANNEY DANIEL | Director | Option Exercise | M | 6.99 | 71,237 | 497,947 | 0 | |
| Jan 22 2018 | ESPR | Esperion Therapeut ... | JANNEY DANIEL | Director | Gift | G | 0.00 | 7,020 | 0 | 0 | 7 K to 0 (-100.00 %) |
| Jan 22 2018 | ESPR | Esperion Therapeut ... | JANNEY DANIEL | Director | Gift | G | 0.00 | 31,466 | 0 | 0 | 31.5 K to 0 (-100.00 %) |
| Jan 22 2018 | ESPR | Esperion Therapeut ... | JANNEY DANIEL | Director | Payment of Exercise | F | 74.96 | 6,640 | 497,734 | 624,564 | 631.2 K to 624.6 K (-1.05 %) |
| Jan 22 2018 | ESPR | Esperion Therapeut ... | JANNEY DANIEL | Director | Buy | M | 6.99 | 71,237 | 497,947 | 631,204 | 560 K to 631.2 K (+12.72 %) |
| Jan 04 2018 | VIVMF | VIVEVE MEDICAL, IN ... | JANNEY DANIEL | Director | Grant | A | 0.00 | 4,276 | 0 | 15,614 | 11.3 K to 15.6 K (+37.71 %) |
| Oct 04 2017 | VIVMF | VIVEVE MEDICAL, IN ... | JANNEY DANIEL | Director | Grant | A | 0.00 | 2,872 | 0 | 11,338 | 8.5 K to 11.3 K (+33.92 %) |
| Sep 25 2017 | KRYS | Krystal Biotech, I ... | JANNEY DANIEL | Director | Option Exercise | C | 0.00 | 124,456 | 0 | 0 | |
| Sep 25 2017 | KRYS | Krystal Biotech, I ... | JANNEY DANIEL | Director | Buy | C | 0.00 | 124,456 | 0 | 455,046 | 330.6 K to 455 K (+37.65 %) |
| Sep 25 2017 | KRYS | Krystal Biotech, I ... | JANNEY DANIEL | Director | Buy | P | 10.00 | 200,000 | 2,000,000 | 330,590 | 130.6 K to 330.6 K (+153.15 %) |
| Sep 08 2017 | VIVMF | VIVEVE MEDICAL, IN ... | JANNEY DANIEL | Director | Option Exercise | A | 5.58 | 17,500 | 97,650 | 17,500 | |
| Sep 08 2017 | VIVMF | VIVEVE MEDICAL, IN ... | JANNEY DANIEL | Director | Grant | A | 0.00 | 3,025 | 0 | 8,466 | 5.4 K to 8.5 K (+55.60 %) |
| May 19 2017 | VIVMF | VIVEVE MEDICAL, IN ... | JANNEY DANIEL | Director | Grant | A | 0.00 | 2,387 | 0 | 5,441 | 3.1 K to 5.4 K (+78.16 %) |
| May 19 2017 | VIVMF | VIVEVE MEDICAL, IN ... | JANNEY DANIEL | Director | Grant | A | 0.00 | 2,387 | 0 | 5,441 | 3.1 K to 5.4 K (+78.16 %) |
| Apr 19 2017 | ESPR | Esperion Therapeut ... | JANNEY DANIEL | Director | Option Exercise | A | 38.96 | 14,000 | 545,440 | 14,000 | |
| Mar 23 2017 | ESPR | Esperion Therapeut ... | JANNEY DANIEL | Director | Sell | S | 48.19 | 700 | 33,733 | 1,359,967 | 1.4 M to 1.4 M (-0.05 %) |
| Mar 23 2017 | ESPR | Esperion Therapeut ... | JANNEY DANIEL | Director | Sell | S | 47.54 | 56,855 | 2,702,887 | 1,360,667 | 1.4 M to 1.4 M (-4.01 %) |
| Mar 23 2017 | ESPR | Esperion Therapeut ... | JANNEY DANIEL | Director | Sell | S | 46.60 | 59,798 | 2,786,587 | 1,417,522 | 1.5 M to 1.4 M (-4.05 %) |
| Mar 23 2017 | ESPR | Esperion Therapeut ... | JANNEY DANIEL | Director | Sell | S | 45.43 | 111,307 | 5,056,677 | 1,477,320 | 1.6 M to 1.5 M (-7.01 %) |
| Mar 23 2017 | ESPR | Esperion Therapeut ... | JANNEY DANIEL | Director | Sell | S | 44.91 | 121,340 | 5,449,379 | 1,588,627 | 1.7 M to 1.6 M (-7.10 %) |
| Mar 21 2017 | VIVMF | VIVEVE MEDICAL, IN ... | JANNEY DANIEL | Director | Buy | P | 4.00 | 500,000 | 2,000,000 | 1,381,955 | 882 K to 1.4 M (+56.69 %) |
| Dec 28 2016 | VIVMF | VIVEVE MEDICAL, IN ... | JANNEY DANIEL | Director | Option Exercise | A | 5.22 | 11,035 | 57,603 | 11,035 | |
| Nov 14 2016 | VIVMF | VIVEVE MEDICAL, IN ... | JANNEY DANIEL | Director | Grant | A | 0.00 | 1,775 | 0 | 3,054 | 1.3 K to 3.1 K (+138.78 %) |
| Aug 24 2016 | VIVMF | VIVEVE MEDICAL, IN ... | JANNEY DANIEL | Director | Option Exercise | A | 7.89 | 4,590 | 36,215 | 4,590 | |
| Aug 24 2016 | VIVMF | VIVEVE MEDICAL, IN ... | JANNEY DANIEL | Director | Grant | A | 0.00 | 1,279 | 0 | 1,279 | 0 to 1.3 K |
| Jun 10 2016 | ESPR | Esperion Therapeut ... | JANNEY DANIEL | Director | Option Exercise | A | 17.75 | 8,000 | 142,000 | 8,000 | |
| Jan 29 2016 | VIVMF | VIVEVE MEDICAL, IN ... | JANNEY DANIEL | Director | Option Exercise | P | 0.53 | 202,000 | 107,060 | 202,000 | |
| Dec 18 2015 | VIVMF | VIVEVE MEDICAL, IN ... | JANNEY DANIEL | Director | Option Exercise | A | 0.75 | 108,000 | 81,000 | 155,000 | |
| Nov 25 2015 | VIVMF | VIVEVE MEDICAL, IN ... | JANNEY DANIEL | Director | Buy | P | 0.70 | 857,142 | 599,999 | 5,455,632 | 4.6 M to 5.5 M (+18.64 %) |
| Jun 17 2015 | NEOT | Neothetics, Inc. | JANNEY DANIEL | Director | Option Exercise | A | 6.29 | 12,450 | 78,311 | 12,450 | |
| Jun 17 2015 | NEOT | Neothetics, Inc. | JANNEY DANIEL | Director | Option Exercise | A | 6.29 | 23,940 | 150,583 | 23,940 | |
| May 18 2015 | ESPR | Esperion Therapeut ... | JANNEY DANIEL | Director | Option Exercise | A | 107.74 | 8,000 | 861,920 | 8,000 | |
| May 14 2015 | VIVMF | VIVEVE MEDICAL, IN ... | JANNEY DANIEL | Director | Buy | P | 0.37 | 2,702,702 | 1,000,000 | 4,598,490 | 1.9 M to 4.6 M (+142.56 %) |
Page: 1